On the recordOctober 25, 2023
The GAO found that an emphasis on profits can lead private equity backed IRBs to rubber stamp reviews of drug clinical trials.
Source
congress.govThe GAO found that an emphasis on profits can lead private equity backed IRBs to rubber stamp reviews of drug clinical trials.
Warren highlights the risks of profit-driven reviews in clinical trials.
Share
More from Elizabeth Warren
At the same time that it is refusing to invest in workers at its existing facilities in New England, the company is pouring money into its new ventures, including a casino in the United Arab Emirates.
The President has in fact accepted the ring as part of a quid pro quo agreement to reduce diamond tariffs.
At a moment that calls for independent, transparent, and enforceable safeguards, the American people have been left with an entirely voluntary, industry-designed oversight process.
That means families are paying $3,772 more thanks to inflation under Trump.